A narrative review on perioperative systemic therapy in non-small cell lung cancer.

Autor: Hsu R; Division of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA., Arter ZL; Department of Medicine, Division of Hematology-Oncology, University of California Irvine School of Medicine, Orange, CA 92697, USA., Poei D; Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA., Benjamin DJ; Hoag Family Cancer Institute, Newport Beach, CA 92663, USA.

Publikováno v: Exploration of targeted anti-tumor therapy [Explor Target Antitumor Ther] 2024; Vol. 5 (4), pp. 931-954. Date of Electronic Publication: 2024 Jul 26.

Real world prognostic utility of platelet lymphocyte ratio and nutritional status in first-line immunotherapy response in stage IV non-small cell lung cancer.

Autor: MacDonald M; Department of Internal Medicine, University of Southern California, Los Angeles, CA, United States., Poei D; Department of Internal Medicine, University of Southern California, Los Angeles, CA, United States., Leyba A; Department of Internal Medicine, University of Southern California, Los Angeles, CA, United States., Diep R; California University of Science and Medicine SOM, Colton, CA, United States., Chennapan K; Department of Internal Medicine, University of Southern California, Los Angeles, CA, United States., Leon C; Department of Surgery, University of Southern California, Los Angeles, CA, United States., Xia B; Department of Internal Medicine, Division of Medical Oncology, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, United States., Nieva JJ; Department of Internal Medicine, Division of Medical Oncology, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, United States., Hsu R; Department of Internal Medicine, Division of Medical Oncology, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, United States. Electronic address: robert.hsu@med.usc.edu.

Publikováno v: Cancer treatment and research communications [Cancer Treat Res Commun] 2023; Vol. 36, pp. 100752. Date of Electronic Publication: 2023 Aug 18.

Navigating the Complexity of Resistance in Lung Cancer Therapy: Mechanisms, Organoid Models, and Strategies for Overcoming Treatment Failure.

Autor: Kang, Da Hyun¹ (AUTHOR) ibelieveu113@cnuh.co.kr, Lee, Jisoo² (AUTHOR) jisoo98lee@gmail.com, Im, Subin² (AUTHOR), Chung, Chaeuk¹ (AUTHOR) universe7903@gmail.com

Publikováno v: Cancers. Dec2024, Vol. 16 Issue 23, p3996. 20p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Use of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer Treatment—Literature Review.

Autor: Gorzelak-Magiera, Anita, Domagała-Haduch, Małgorzata, Kabut, Jacek, Gisterek-Grocholska, Iwona

Publikováno v: Biomedicines; Oct2024, Vol. 12 Issue 10, p2308, 12p